Data / Form D filings / Armis Biopharma, Inc.
Armis Biopharma, Inc.: Form D filings
Armis Biopharma, Inc., a health care company in Fort Collins, CO, filed 14 Form D notices with the SEC between 2014 and 2025. The latest, on July 10, 2025, reports $1 million sold of a $3 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2401 RESEARCH BLVD, SUITE 205, Fort Collins, CO, 80526
- Phone
- (970) 295-4373
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1604801
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 10, 2025 | New notice | $3,000,000 | $1,000,000 | $2,000,000 | 1 | Jun 27, 2025 | sec.gov |
| Sep 15, 2022 | Amendment | $10,000,000 | $7,270,000 | $2,730,000 | 14 | May 15, 2020 | sec.gov |
| Feb 15, 2022 | New notice | $8,000,000 | $5,270,000 | $2,730,000 | 14 | May 15, 2020 | sec.gov |
| Sep 25, 2018 | New notice | $10,000,000 | $1,832,300 | $8,167,700 | 19 | Jun 22, 2018 | sec.gov |
| Nov 17, 2017 | New notice | $30,000,000 | $125,000 | $29,875,000 | 1 | Oct 30, 2017 | sec.gov |
| Nov 17, 2017 | Amendment | $14,000,000 | $2,744,835 | $11,255,165 | 7 | Feb 16, 2017 | sec.gov |
| May 12, 2017 | Amendment | $14,000,000 | $2,744,835 | $11,255,165 | 7 | Feb 16, 2017 | sec.gov |
| Feb 9, 2017 | Amendment | $14,000,000 | $0 | $14,000,000 | 0 | Yet to occur | sec.gov |
| Jan 27, 2017 | New notice | $14,000,000 | $0 | $14,000,000 | 0 | Yet to occur | sec.gov |
| Jun 1, 2016 | Amendment | $5,799,999 | $3,255,561 | $2,544,438 | 16 | Jan 27, 2016 | sec.gov |
| Mar 10, 2016 | New notice | $5,799,999 | $758,299 | $5,041,700 | 8 | Jan 27, 2016 | sec.gov |
| Feb 26, 2016 | New notice | $1,736,920 | $1,736,920 | 19 | Mar 16, 2015 | sec.gov | |
| Apr 17, 2014 | Amendment | $3,197,504 | $3,197,504 | 20 | Feb 7, 2014 | sec.gov | |
| Apr 14, 2014 | New notice | $2,517,720 | $2,517,720 | 20 | Feb 7, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Theodore Ziemann | Director | |
| Alan Ruud | Director | |
| Steve Coder | Executive Officer, Director | |
| Michael Voss | Executive Officer, Director | |
| William Nelson, MD, Ph.D. | Director | |
| Michael Litwack | Director | |
| Alan Smith, Ph.D. | Director | |
| Christopher Rudd | Director |
Other health care companies in Colorado that filed recently
- Smith Medical Direct Specialty Care Surgery Center of Denver P.C. $800,000 · Oct 23, 2026
- Entirely Well Inc. $230,000 · Oct 23, 2026
- SeaStar Medical Holding Corp $3.3 million · Oct 8, 2026
- CARING CLOSURES INT'L LLC offering · Sep 17, 2026
- ENCISION INC $80,000 · Sep 17, 2026
- Psio, Inc. $100,000 · Aug 17, 2026
Every Form D from the week of Jul 7, 2025 · All recent filings in Colorado · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Armis Biopharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.